Delivery available in 411014 area only.

JAKAVI 5mg Tablet 14’s

Original price was: ₹25,970.00.Current price is: ₹22,074.50.

  • JAKAVI 5mg Tablet 10’s
  • Treats myelofibrosis, polycythemia vera, and acute graft versus host disease
  • Inhibits Janus kinase (JAK) enzymes to reduce symptoms and progression of these conditions
  • Improves spleen size and symptoms such as fatigue, abdominal discomfort, and night sweats

Out of stock

SKU: PS011032 Category:
Trust Badge Image
Description

Description

JAKAVI 5mg Tablet 10’s jakavi 5mg tablets, a crucial component in personalized cancer care, are designed to target myeloproliferative neoplasms (mpns) and acute myeloid leukemia (aml) with a jak1, jak2, and flt3 inhibitor. Each tablet contains 5mg of Ruxolitinib, a potent pharmaceutical agent that helps manage symptoms associated with these conditions. The tablets are supplied in packs of 10 for convenient dosing. JAKAVI is FDA-approved and has demonstrated significant efficacy in improving spleen size, symptoms, and hematologic response in patients with MPNs. This medication is a vital tool in the ongoing management of these complex diseases.

Reviews (0)

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

More Offers
No more offers for this product!
Inquiries

General Inquiries

There are no inquiries yet.

Shopping cart

0
image/svg+xml

No products in the cart.

Continue Shopping